Navigation Links
Meeting highlights the role of molecular imaging biomarkers in clinical research and therapeutics
Date:10/1/2009

Reston, Va.SNM is collaborating with the International Partnership for Critical Markers of Disease (CMOD) during CMOD's 7th Annual Biomarkers and Surrogate Endpoints Symposium, Bethesda North Marriott Hotel and Conference Center, Bethesda, Md., Oct. 19󈞁, 2009. The joint session, co-hosted by SNM and CMOD, will be held on Wednesday, Oct. 21, from 12:30 p.m. to 4:15 p.m.

"We are pleased to further extend our collaboration with the International Partnership for Critical Markers of Disease by holding this joint session on molecular imaging biomarkers in clinical research," said Michael Graham, PhD, MD, SNM president and director of nuclear medicine at the University of Iowa Carver College of Medicine. "We have established a vital scientific partnership to promote the expanded use and validation of molecular imaging biomarkers for clinical trials. Improved availability and performance of molecular imaging biomarkers will facilitate the development of safe and effective therapeutic drugs and ultimately enhance the delivery of personalized medicine."

"Our common interest in accelerating scientific research and therapeutic drug development by creating novel and advanced biomarkers to promote optimal health care today is a model for others to follow," said Therese Heinonen, DVM, executive director and co-founder of the International Partnership for Critical Markers of Disease and associate director of scientific affairs, Montreal Heart Institute Coordinating Center. "SNM and CMOD share the vision of expanding the use of these biomarkers in a standardized clinical research environment where providing high-quality, cost-effective patient care is the ultimate goal."

Peter Libby (co-founder of CMOD and Mallinckrodt Professor of Medicine at Harvard Medical School and chief of cardiovascular medicine at Brigham and Women's Hospital) will moderate the special afternoon session with Michael Graham. Don Black, general manager of molecular imaging at GE Healthcare's Medical Diagnostics, and Alexander J.B. McEwan, MD, chair of the department of oncology at the University of Alberta, Canada, will present perspectives on standardizing molecular imaging clinical trials, with an emphasis on the challenges of developing molecular imaging agents and statistical considerations in trial design. The second panel, led by Dan Skovronsky, founder and CEO of Avid Pharmaceuticals, and Patricia Cole, executive director of Imagepace at Medpace, Inc., will discuss the potential role of molecular imaging biomarkers in therapeutic development in both oncology and neurologytwo areas of significant interest to clinicians, researchers and industry. The session concludes with presentations focused on challenges and opportunities for using molecular imaging biomarkers in clinical research.


'/>"/>

Contact: Amy Shaw
ashaw@snm.org
703-652-6773
Society of Nuclear Medicine
Source:Eurekalert

Related medicine news :

1. Pelosi and Hoyer Remarks at Press Availability Following Leadership Meeting
2. 2009 American Association of Pharmaceutical Scientists Annual Meeting and Exposition
3. American Society of Plastic Surgeons hosts 78th annual meeting
4. American Society Of Plastic Surgeons Hosts 78th Annual Meeting
5. American Heart Association Meeting Report: High-Sugar Diet Increases Mens Blood Pressure; Gout Drug Protective
6. Data Released at an International Stem Cell Meeting Highlights Effectiveness of New Patient Education System Developed to Support Federal and State Guidelines on Cord Blood Education
7. Cardiogenesis Announces Successful Symposium at the Transcatheter Cardiovascular Therapeutics (TCT) Meeting
8. SpectraScience Announces Results of Annual Shareholder Meeting
9. Maternal/child health focus of African Science Academies meeting in Ghana Nov. 9-11
10. Allied Worlds Linda McSmith to Speak at Ohio Association of Ambulatory Surgery Centers Annual Meeting
11. Dean MacCarter, Ph.D. Addressed Differentiation of Responder vs Non-Responder CRT Status with Low Level Exercise at HFSA13th Annual Scientific Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... (PRWEB) , ... February 09, 2016 , ... ... Transformation Solutions, LLC to help enterprises move workloads to the cloud. Cirracore ... connect to their cloud without traversing the Internet. Transformation Solutions (TSL Partners) ...
(Date:2/9/2016)... ... , ... Establishment Labs, a global breast implant and medical technology company, is ... Directors. , “We are honored to welcome David to our Board of ... Chacon Quiros, CEO of Establishment Labs. "David’s knowledge and experience will be invaluable to ...
(Date:2/9/2016)... ... February 09, 2016 , ... The Bon-Ton Stores, ... Younkers department stores, announced it has raised $176,000 to benefit the Breast Cancer ... Cancer Center at the University of Iowa, The Lynn Sage Cancer Research Foundation, ...
(Date:2/9/2016)... ... ... METTLER TOLEDO has published a new guide entitled “Essential ... the techniques they use so they can more easily spot potential error sources ... to create a leaner overall lab experience. , The new guide offers ...
(Date:2/9/2016)... ... February 09, 2016 , ... United Methodist Communications ... of Prevention,” an animated video designed to prevent the next widespread ... the video are being distributed throughout Togo, Liberia, Sierra Leone, Nigeria, Côte d’Ivoire ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)... Feb. 9, 2016  Axovant Sciences Ltd. (NYSE: ... the treatment of dementia, today announced further details ... behavioral and functional aspects of Lewy body dementia, ... the U.S. Two out of the three studies ... to start later this quarter. In addition, the ...
(Date:2/9/2016)... The new report "Global Diagnostic Ultrasound Devices Market Assessment ... reveals that global diagnostic ultrasound devices market was valued at US$ ... million by 2019 at a CAGR of 6.8% from 2015 to ... has been analyzed for six geographies of North America ... , Latin America , Middle-East ...
(Date:2/9/2016)... 9, 2016 The new report "Global Blood Monitoring & Cardiac Monitoring ... & Consulting group reveals that global market for blood monitoring & ... and expected to grow to US$ 24,830.1 million by 2019 at ... North America , Europe , ... Middle-East and Africa . The three ...
Breaking Medicine Technology: